Table 2 ROC curve analyses for the serum HO-1 level and other parameters to predict 3-month mortality among patients with acute exacerbation.
Variable | N | AUC | Best cut-off value | Sensitivity, % | Specificity, % | P value |
|---|---|---|---|---|---|---|
Serum HO-1, ng/mL | 51 | 0.71 | 41.8 | 62 | 74 | 0.016 |
P/F ratio | 39 | 0.58 | 198 | 50 | 78 | 0.793 |
Serum LDH, U/L | 51 | 0.59 | 336 | 54 | 71 | 0.446 |
Serum SP-D, ng/mL | 46 | 0.41 | 1280 | 15 | 100 | 0.384 |
Serum KL-6, U/mL | 50 | 0.71 | 406 | 54 | 84 | 0.043 |
Honeycomb score | 51 | 0.55 | 3 | 85 | 39 | 0.891 |
GGO score | 51 | 0.63 | 8 | 92 | 34 | 0.137 |